# Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease

> **NCT07351773** · NA · COMPLETED · sponsor: **Taizhou Second People's Hospital** · enrollment: 40 (actual)

## Conditions studied

- Alzheimer's Disease(AD)
- Cognitive Dysfunction

## Interventions

- **PROCEDURE:** Ultrasound-Guided Stellate Ganglion Block
- **DRUG:** Memantine hydrochloride
- **DRUG:** Donepezil hydrochloride

## Key facts

- **NCT ID:** NCT07351773
- **Lead sponsor:** Taizhou Second People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-01-26
- **Primary completion:** 2025-06-29
- **Final completion:** 2025-11-29
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07351773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07351773, "Ultrasound-Guided Stellate Ganglion Block for Alzheimer's Disease". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT07351773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*